A team of researchers says it has developed a new and innovative screening technique that can be used for detecting ovarian cancer in twice as many women, compared to other screening methods available at the moment.
Ovarian cancer is one of the deadliest types of cancer because it is usually diagnosed when it’s already at an advanced stage.
But now, according to the results collected from the UK Collaborative Trial of Ovarian Cancer Screening, which is the largest screening trial for ovarian cancer in the world, the new method could help detect more cases, thus saving more lives.
The new trial was led by a team of researchers from the University College London and used a algorithm to determine the levels of the blood protein called CA125, which is also known as the biomarker or the tumor marker.
This protein is found in a bigger concentration in tumor cells, compared to other cells of the body. The CA125 protein is present more in ovarian cancer cells and is tested in women who have an increased risk of developing the disease.
Although testing to see if a patient has the CA15 is not a new method, the algorithm, called ROCA, is.
According to the researchers, the new algorithm was accurate in detecting ovarian cancer in women in 86% of the cases, compared to other screening methods that usually identify fewer cases, between 41 and 46%.
Professor Usha Menon, one of the lead researchers involved in the new trial, said that the new ROCA method has the potential to be used as a regular cancer screening tool.
Menon said that there will be additional costs to run the ROCA screening test and will be available soon.
The scientists said that a little more time is needed in order to decide about the screening for ovarian cancer.
When they will get the complete results, the researchers will be able to say whether by detecting the cancer at an early stage helped save the lives of the women involved in the trial.
The researchers said that so far, the results of the study are very promising and the method could soon be used as a strategy to detect the disease in its early stage.
The next step would be to study the mortality rates.
According to the American Cancer Society’s latest estimates, in 2015 there will be approximately 21,290 new cases of ovarian cancer, and about 14,180 of the women will die because of it.
Image Source: kenes